Table 2.

Treatment costs with PEGasparaginase (scenario 1) for patients with and without an allergic reaction to PEGasparaginase. Scenario 1: PEGasparaginase used as first-line treatment in intensification; and switch to Erwinia asparaginase as second-line after PEGasparaginase allergy.

Table 2.